LONDON (Reuters) - Merck & Co's diabetes drug Januvia substantially improves blood sugar levels over two years of treatment when combined with the older drug metformin and is generally well tolerated, new data on Tuesday showed.

ALEXANDRIA, VA, Sep 09, 2008 (MARKET WIRE via COMTEX) -- Click on the following link to view ADA Men's Health Campaign Video: http://www.firstlinemedia.com/video/ADA_Mens_Health_Campaign_v5.wmv .

NEW YORK (Reuters Health) - A newer, longer-acting form of Byetta (exenatide) that is given once weekly actually achieves better blood sugar control in diabetics than does the standard formulation, which is given twice daily, according to a ...

WASHINGTON (Reuters) - Devices that constantly monitor blood sugar levels of people with diabetes help them control their glucose better than the old-fashioned method of pricking their fingers throughout the day, researchers reported on Mond...

CHENNAI, India (Reuters Health) - Researchers from north India report that 21.1 percent of affluent adults have type 2 diabetes, the highest figures from India so far.

NEW YORK (Reuters Health) - People with diabetes, coronary heart disease, and chronic kidney disease benefit from having their cholesterol levels lowered aggressively with high doses of Lipitor, according to a Mayo Clinic report.

NEW YORK (Reuters Health) - Obese people with diabetes are just as likely to go undiagnosed as their slimmer peers with the disease, Harvard Medical School researchers report.

NEW YORK - Scientists have transformed one type of cell into another in living mice, a big step toward the goal of growing replacement tissues to treat a variety of diseases.

NEW YORK - Scientists have transformed one type of cell into another in living mice, a big step toward the goal of growing replacement tissues to treat a variety of diseases.

BOSTON (Reuters) - Amylin Pharmaceuticals Inc said there have been four deaths among patients with pancreatitis who took its diabetes drug, Byetta, in addition to two deaths reported last week by U.S.

BOSTON (Reuters) - Amylin Pharmaceuticals Inc said there have been four deaths among patients with pancreatitis who took its diabetes drug, Byetta, in addition to two deaths reported last week by U.S.

NEW YORK (Reuters Health) - Metabolic syndrome, a cluster of conditions that increases the risk of heart disease, stroke and diabetes, in extremely obese patients can be cured by gastric bypass surgery, according to the findings from a new s...

NEW YORK (Reuters Health) - Metabolic syndrome, a cluster of conditions that increases the risk of heart disease, stroke and diabetes, in extremely obese patients can be cured by gastric bypass surgery, according to the findings from a new s...

WASHINGTON - Many people in Medicare with diabetes, high blood pressure and other chronic conditions stop taking their medicine when faced with picking up the entire cost of their prescriptions, researchers say.

WASHINGTON - Many people in Medicare with diabetes, high blood pressure and other chronic conditions stop taking their medicine when faced with picking up the entire cost of their prescriptions, researchers say.

CHICAGO - A new analysis of government data is the first to link low-level arsenic exposure, possibly from drinking water, with Type 2 diabetes, researchers say.

CHICAGO - A new analysis of government data is the first to link low-level arsenic exposure, possibly from drinking water, with Type 2 diabetes, researchers say.

NEW YORK (Reuters Health) - The risk of having a foot or leg amputated remains high among patients with type 1 or "insulin-dependent" diabetes, according to findings from a Swedish study.

NEW YORK (Reuters Health) - The risk of having a foot or leg amputated remains high among patients with type 1 or "insulin-dependent" diabetes, according to findings from a Swedish study.

WASHINGTON - Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc.

WASHINGTON - Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc.

NEW YORK (Reuters Health) - Researchers from Denmark say they have "strong evidence" that diabetes is associated with a 25 percent to 75 percent increase in the relative risk of hospitalization due to pneumonia.

NEW YORK (Reuters Health) - Researchers from Denmark say they have "strong evidence" that diabetes is associated with a 25 percent to 75 percent increase in the relative risk of hospitalization due to pneumonia.

NEW YORK (Reuters Health) - People who have been exposed to high levels of toxic polychlorinated biphenyls (PCBs) may face an elevated risk of type 2 diabetes, a new study shows.

NEW YORK (Reuters Health) - People who have been exposed to high levels of toxic polychlorinated biphenyls (PCBs) may face an elevated risk of type 2 diabetes, a new study shows.